Certoparin and Apixaban: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Certoparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines are blood thinners. Apixaban (Eliquis) and certoparin work in different ways, but they both make it harder for your blood to clot. When you take them together, that clot-blocking effect stacks up, so your risk of bleeding goes up. In some cases that bleeding can be serious.
Watch for warning signs like unusual bruising, pink or red urine, black or bloody stools, coughing or vomiting blood, or bleeding that won't stop. If any of these happen, get emergency help right away. The good news is your care team knows how to handle this. Please don't stop either drug on your own, just talk with your doctor or pharmacist.
Mechanism: additive anticoagulation. Both apixaban (direct factor Xa inhibitor) and certoparin (low molecular weight heparin acting largely via anti-Xa) suppress factor Xa, so combined use produces additive pharmacodynamic effect and increased bleeding risk. Neither is a prodrug.
- Direction/magnitude: additive; PD studies with apixaban plus enoxaparin showed a 50-60% rise in anti-Xa activity.
- Evidence: probable. Severity: major.
- Management: avoid overlap unless clinically justified; monitor for bleeding. Discontinue apixaban if active pathologic bleeding occurs. Apixaban PD effect persists at least 24 hours. A specific reversal agent for anti-Xa activity is available; PCC, aPCC, or rFVIIa may be considered.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
Using apixaban, a factor Xa inhibitor, together with another anticoagulant raises the likelihood of bleeding. Pharmacodynamic interaction studies involving apixaban showed that giving apixaban alongside enoxaparin produced a 50% to 60% rise in anti-factor Xa activity. Should active pathological bleeding develop, apixaban should be stopped. A product capable of reversing apixaban's anti-factor Xa activity exists. Apixaban's pharmacodynamic effect is anticipated to remain for a minimum of 24 hours following the final dose. Patients should be counseled about the signs and symptoms of blood loss and instructed to report them without delay or proceed to an emergency room. Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa are options that may be considered. If PCCs are administered, tracking apixaban's anticoagulant effect through a clotting assay (PT, INR, or aPTT) or anti-factor Xa (FXa) activity offers no benefit and is not advised. Activated oral charcoal decreases apixaban absorption, which in turn reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Doctors sometimes combine anticoagulants deliberately during a transition, but they watch closely because the bleeding risk adds up.
- Your care team may adjust and individualize your therapy and monitor you more closely while both are on board.
- Learn the signs of bleeding: unusual bruising, blood in urine or stool, black stools, coughing or vomiting blood, or bleeding that won't stop.
- Report these immediately or go to an emergency room. A reversal agent for apixaban is available if serious bleeding occurs.
Raise any questions about combining these with your pharmacist or prescriber.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In investigations examining pharmacodynamic drug interactions involving apixaban, a 50% to 60% rise in anti-factor Xa activity was noted when apixaban and enoxaparin were given together 1.
Common questions
Can I take Certoparin and Apixaban together?
Taking apixaban and certoparin together adds up their blood-thinning effects and raises your bleeding risk, so use them together only under your care team's direction and get emergency help for any serious bleeding. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Certoparin and Apixaban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Certoparin and Apixaban interaction managed?
Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Doctors sometimes combine anticoagulants deliberately during a transition, but they watch closely because the bleeding risk adds up. Your care team may adjust and individualize your therapy and monitor you more closely while both are on board. Learn the signs of bleeding: unusual bruising, blood in urine o… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Certoparin or Apixaban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Apixaban
Keep reading about Certoparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist